317 related articles for article (PubMed ID: 30145780)
21. Dynamic interaction between TAL1 oncoprotein and LSD1 regulates TAL1 function in hematopoiesis and leukemogenesis.
Li Y; Deng C; Hu X; Patel B; Fu X; Qiu Y; Brand M; Zhao K; Huang S
Oncogene; 2012 Nov; 31(48):5007-18. PubMed ID: 22310283
[TBL] [Abstract][Full Text] [Related]
22. TAL1 cooperates with PI3K/AKT pathway activation in T-cell acute lymphoblastic leukemia.
Thielemans N; Demeyer S; Mentens N; Gielen O; Provost S; Cools J
Haematologica; 2022 Oct; 107(10):2304-2317. PubMed ID: 35354248
[TBL] [Abstract][Full Text] [Related]
23. Chromatin looping defines expression of TAL1, its flanking genes, and regulation in T-ALL.
Zhou Y; Kurukuti S; Saffrey P; Vukovic M; Michie AM; Strogantsev R; West AG; Vetrie D
Blood; 2013 Dec; 122(26):4199-209. PubMed ID: 24200685
[TBL] [Abstract][Full Text] [Related]
24. Suppression of super-enhancer-driven TAL1 expression by KLF4 in T-cell acute lymphoblastic leukemia.
Noura M; Matsuo H; Yasuda T; Tsuzuki S; Kiyoi H; Hayakawa F
Oncogene; 2024 Feb; 43(6):447-456. PubMed ID: 38102337
[TBL] [Abstract][Full Text] [Related]
25. FOXP3 can modulate TAL1 transcriptional activity through interaction with LMO2.
Fleskens V; Mokry M; van der Leun AM; Huppelschoten S; Pals CE; Peeters J; Coenen S; Cardoso BA; Barata JT; van Loosdregt J; Coffer PJ
Oncogene; 2016 Aug; 35(31):4141-8. PubMed ID: 26686090
[TBL] [Abstract][Full Text] [Related]
26. The transcription factor TAL1 and miR-17-92 create a regulatory loop in hematopoiesis.
Meyer A; Herkt S; Kunze-Schumacher H; Kohrs N; Ringleb J; Schneider L; Kuvardina ON; Oellerich T; Häupl B; Krueger A; Seifried E; Bonig H; Lausen J
Sci Rep; 2020 Dec; 10(1):21438. PubMed ID: 33293632
[TBL] [Abstract][Full Text] [Related]
27. MiR-146b negatively regulates migration and delays progression of T-cell acute lymphoblastic leukemia.
Correia NC; Fragoso R; Carvalho T; Enguita FJ; Barata JT
Sci Rep; 2016 Aug; 6():31894. PubMed ID: 27550837
[TBL] [Abstract][Full Text] [Related]
28. UTX inhibition as selective epigenetic therapy against TAL1-driven T-cell acute lymphoblastic leukemia.
Benyoucef A; Palii CG; Wang C; Porter CJ; Chu A; Dai F; Tremblay V; Rakopoulos P; Singh K; Huang S; Pflumio F; Hébert J; Couture JF; Perkins TJ; Ge K; Dilworth FJ; Brand M
Genes Dev; 2016 Mar; 30(5):508-21. PubMed ID: 26944678
[TBL] [Abstract][Full Text] [Related]
29. ToTAL1y degraded - rapid dTAG proteolysis of TAL1 in T-cell acute lymphoblastic leukemia.
Costa JR; Mansour MR
Haematologica; 2024 May; 109(5):1325-1327. PubMed ID: 38105739
[No Abstract] [Full Text] [Related]
30. TRIB2 reinforces the oncogenic transcriptional program controlled by the TAL1 complex in T-cell acute lymphoblastic leukemia.
Tan SH; Yam AW; Lawton LN; Wong RW; Young RA; Look AT; Sanda T
Leukemia; 2016 Apr; 30(4):959-62. PubMed ID: 26202930
[No Abstract] [Full Text] [Related]
31. microRNAs regulate TAL1 expression in T-cell acute lymphoblastic leukemia.
Correia NC; Melão A; Póvoa V; Sarmento L; Gómez de Cedrón M; Malumbres M; Enguita FJ; Barata JT
Oncotarget; 2016 Feb; 7(7):8268-81. PubMed ID: 26882564
[TBL] [Abstract][Full Text] [Related]
32. Monoallelic
Veiga DFT; Tremblay M; Gerby B; Herblot S; Haman A; Gendron P; Lemieux S; Zúñiga-Pflücker JC; Hébert J; Cohen JP; Hoang T
Front Immunol; 2022; 13():867443. PubMed ID: 35401501
[TBL] [Abstract][Full Text] [Related]
33. Isoforms of the TAL1 transcription factor have different roles in hematopoiesis and cell growth.
Sharma A; Mistriel-Zerbib S; Najar RA; Engal E; Bentata M; Taqatqa N; Dahan S; Cohen K; Jaffe-Herman S; Geminder O; Baker M; Nevo Y; Plaschkes I; Kay G; Drier Y; Berger M; Salton M
PLoS Biol; 2023 Jun; 21(6):e3002175. PubMed ID: 37379322
[TBL] [Abstract][Full Text] [Related]
34. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
[TBL] [Abstract][Full Text] [Related]
35. Stem Cell Leukemia: how a TALented actor can go awry on the hematopoietic stage.
Correia NC; Arcangeli ML; Pflumio F; Barata JT
Leukemia; 2016 Oct; 30(10):1968-1978. PubMed ID: 27443261
[TBL] [Abstract][Full Text] [Related]
36. SIX6 is a TAL1-regulated transcription factor in T-ALL and associated with inferior outcome.
Laukkanen S; Oksa L; Nikkilä A; Lahnalampi M; Parikka M; Seki M; Takita J; Degerman S; de Bock CE; Heinäniemi M; Lohi O
Leuk Lymphoma; 2020 Dec; 61(13):3089-3100. PubMed ID: 32835548
[TBL] [Abstract][Full Text] [Related]
37. TAL1/SCL is downregulated upon histone deacetylase inhibition in T-cell acute lymphoblastic leukemia cells.
Cardoso BA; de Almeida SF; Laranjeira AB; Carmo-Fonseca M; Yunes JA; Coffer PJ; Barata JT
Leukemia; 2011 Oct; 25(10):1578-86. PubMed ID: 21647153
[TBL] [Abstract][Full Text] [Related]
38. The Role of TAL1 in Hematopoiesis and Leukemogenesis.
Vagapova ER; Spirin PV; Lebedev TD; Prassolov VS
Acta Naturae; 2018; 10(1):15-23. PubMed ID: 29713515
[TBL] [Abstract][Full Text] [Related]
39. Novel TAL1 targets beyond protein-coding genes: identification of TAL1-regulated microRNAs in T-cell acute lymphoblastic leukemia.
Correia NC; Durinck K; Leite AP; Ongenaert M; Rondou P; Speleman F; Enguita FJ; Barata JT
Leukemia; 2013 Jul; 27(7):1603-6. PubMed ID: 23448994
[No Abstract] [Full Text] [Related]
40. [Understanding of molecular pathogenesis of T-cell leukemia by super-enhancer profiling].
Sanda T
Rinsho Ketsueki; 2018; 59(7):899-908. PubMed ID: 30078801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]